Chemical Structure (Inbrija 01)
Inbrija Capsule
Product Images NDC 10144-342
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Inbrija (NDC 10144-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merz Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Inbrija 02)
The text describes a table or graph displaying data on a variable labeled "quare Mean + SE". The other information present includes a "Least-S" value, "N" value of 15, and two groups labeled "Placebo" and "W INBRWA 84 mg" with respective "N" values of 112 and 114. The graph also includes a time axis labeled in minutes from 20 to 60.*
Figure A (Inbrija 03)
Figure B (Inbrija 04)
Figure C (Inbrija 05)
Figure D (Inbrija 06)
Figure E (Inbrija 07)
The text indicates that there is a tear off package which contains 2 capsules. However, without additional context regarding what the capsules are for or what is depicted in the accompanying Fig.E, the description may not be very useful.*
Figure F (Inbrija 08)
Figure G (Inbrija 09)
Figure H (Inbrija 10)
Figure I (Inbrija 11)
Figure J (Inbrija 12)
Figure K (Inbrija 13)
Not available.*
Figure L (Inbrija 14)
Figure M (Inbrija 15)
Figure N (Inbrija 16)
Figure O (Inbrija 17)
Figure P (Inbrija 18)
Figure Q (Inbrija 19)
Figure R (Inbrija 20)
Figure S (Inbrija 21)
Figure T (Inbrija 22)
Figure U (Inbrija 23)
Inbrija 23a
Figure V (Inbrija 24)
Inbrija 24a
Figure W (Inbrija 25)
Principal Display Panel (42 mg Capsule Blister Pack Carton)
Inbrija is a medication for oral inhalation only, contained in capsules that each contain 42mg levodopa. The capsules should always be stored in the blister and only removed immediately before use. The active ingredients also include DPPC and sodium chloride. The enclosed Patient Information and Instructions for Use should be read before using Inbrija. The NDC number is 10144-342-60.*
Inbrija 27
Inbrija is a levodopa inhalation powder that comes in capsules of 42 mg for oral inhalation only. The capsules should not be swallowed and are intended for a usual dosage which can be found in the prescribing information. Each Inbrija capsule contains 42 mg levodopa and other inactive ingredients such as DPPC, sodium chloride. It should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). Additionally, it should always be stored in the blister and only removed immediately before use. The enclosed patient information and instructions for use should be reviewed before taking. The manufacturing company is Acorda Therapeutics, Inc.*
Inbrija 28
Inbrija is a medication used for oral inhalation only and contains 42 mg levodopa per capsule. The capsules should not be swallowed and should be stored between 20°C to 25°C (68°F to 77°F). The patient information enclosed must be read before use. The medication is manufactured by Acorda Therapeutics and comes in a blister pack with a lot number and expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
